• Intelligent Bio Solutions filed an FDA 510(k) application seeking U.S. clearance for its Intelligent Fingerprinting Drug Screening System to detect codeine.
• Submission includes 2026 clinical data showing over 98% accuracy, over 94% sensitivity, 100% specificity in a method comparison study.
• U.S. clearance would support entry into the multi-billion-dollar U.S. drug screening market beyond forensic-use-only settings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609090830PRIMZONEFULLFEED9822437) on September 09, 2026, and is solely responsible for the information contained therein.